Abstract
Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
CNS & Neurological Disorders - Drug Targets
Title:Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification
Volume: 16 Issue: 1
Author(s): Shui-Hua Wang, Sidan Du, Yin Zhang, Preetha Phillips, Le-Nan Wu, Xian-Qing Chen and Yu-Dong Zhang
Affiliation:
Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
Abstract: Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Export Options
About this article
Cite this article as:
Wang Shui-Hua, Du Sidan, Zhang Yin, Phillips Preetha, Wu Le-Nan, Chen Xian-Qing and Zhang Yu-Dong, Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/1871527315666161111123024
DOI https://dx.doi.org/10.2174/1871527315666161111123024 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotropic Effects of the Rho-kinase Inhibitor Fasudil After Subarachnoid Hemorrhage: A Review of Preclinical and Clinical Studies
Current Vascular Pharmacology Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research The Glutathione System and its Regulation by Neurohormone Melatonin in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation A<sub>3</sub> Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes
Recent Patents on Cardiovascular Drug Discovery The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease
Current Alzheimer Research Meet Our Editorial Board Member:
Current Neuropharmacology The Effects of Cognitive Speed of Processing Training Among Older Adults with Psychometrically- Defined Mild Cognitive Impairment
Current Alzheimer Research Fuzzy Computer-Aided Alzheimer’s Disease Diagnosis Based on MRI Data
Current Alzheimer Research Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics#
Current Alzheimer Research Depression as is Seen by Molecular Spectroscopy. Phospholipid- Protein Balance in Affective Disorders and Dementia
Current Molecular Medicine Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Current Psychopharmacology Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Advancement in Obesity Management: Leptin and Adiponectin Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Current Alzheimer Research Total Bakkenolides Protects Neurons Against Cerebral Ischemic Injury Through Inhibition of Nuclear Factor-κB Activation
CNS & Neurological Disorders - Drug Targets Adaptive Behavior in Williams-Beuren Syndrome, Down Syndrome, and Autism Spectrum Disorder
Current Psychiatry Reviews Chronic Hypoxia Potentiates Age-Related Oxidative Imbalance in Brain Vessels and Synaptosomes
Current Neurovascular Research 18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features
Current Alzheimer Research